Cite
TCT-398 Impact of Long-Term Ticagrelor Monotherapy Following 1-Month Dual Antiplatelet Therapy in Patients Who Underwent Complex Percutaneous Coronary Intervention: Insights From the Global Leaders Trial.
MLA
Serruys, Patrick, et al. “TCT-398 Impact of Long-Term Ticagrelor Monotherapy Following 1-Month Dual Antiplatelet Therapy in Patients Who Underwent Complex Percutaneous Coronary Intervention: Insights From the Global Leaders Trial.” Journal of the American College of Cardiology (JACC), vol. 74, no. 13, Oct. 2019, p. B394. EBSCOhost, https://doi.org/10.1016/j.jacc.2019.08.488.
APA
Serruys, P., Takahashi, K., Chichareon, P., Kogame, N., Tomaniak, M., Modolo, R., Chang, C.-C., Stoll, H.-P., Hamm, C., Steg, P. G., Onuma, Y., Windecker, S., & Valgimigli, M. (2019). TCT-398 Impact of Long-Term Ticagrelor Monotherapy Following 1-Month Dual Antiplatelet Therapy in Patients Who Underwent Complex Percutaneous Coronary Intervention: Insights From the Global Leaders Trial. Journal of the American College of Cardiology (JACC), 74(13), B394. https://doi.org/10.1016/j.jacc.2019.08.488
Chicago
Serruys, Patrick, Kuniaki Takahashi, Ply Chichareon, Norihiro Kogame, Mariusz Tomaniak, Rodrigo Modolo, Chun-Chin Chang, et al. 2019. “TCT-398 Impact of Long-Term Ticagrelor Monotherapy Following 1-Month Dual Antiplatelet Therapy in Patients Who Underwent Complex Percutaneous Coronary Intervention: Insights From the Global Leaders Trial.” Journal of the American College of Cardiology (JACC) 74 (13): B394. doi:10.1016/j.jacc.2019.08.488.